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Abstract
Background: The 8p23.1 duplication syndrome and copy number variation of the 8p23.1 defensin gene cluster are
cytogenetically indistinguishable but distinct at the molecular level. To our knowledge, the 8p23.1 duplication
syndrome has been described at prenatal diagnosis only once and we report our experience with four further
apparent duplications ascertained at prenatal diagnosis.
Methods: Additional material at band 8p23.1 was detected using conventional G-banded cytogenetics in each
case. Multiplex Ligation-dependent Probe Amplification (MLPA) or Fluorescence In Situ Hybridisation (FISH) were
used depending on whether only DNA (Cases 1 and 4) or cytogenetic preparations (Cases 2 and 3) were available
from the laboratory of origin. The extent of the duplication in Case 1 was retrospectively determined using array
Comparative Genomic Hybridisation (array CGH).
Results: Three cases of 8p23.1 duplication syndrome were found (Cases 1 to 3). Two were de novo and continued
to term and the third, a paternally transmitted duplication, was terminated because of a previous child with
psychomotor delay and 8p23.1 duplication syndrome. Case 1 was ascertained with a hypoplastic left heart but the
ventricular septal and interventricular defects, in Cases 2 and 3 respectively, were found after ascertainment for
advanced maternal age. By contrast, case 4 was a maternally transmitted copy number variation of the defensin
cluster with normal outcome.
Conclusions: Our data underline the need to differentiate 8p23.1 duplications from copy number variation of the
defensin cluster using FISH, MLPA or array CGH. Cardiac defects were ascertained by ultrasound in only one of the
three duplication 8p23.1 pregnancies but were visible in two of the three at 21 to 22 weeks gestation. Our results
provide further evidence that both deletion and duplication of the GATA4 transcription factor can give rise to a
variety of conotruncal heart defects with variable penetrance and expressivity.
Background
The application of array CGH is rapidly identifying new
recurrent microdeletion and microduplication syn-
dromes [1] and a previously unsuspected level of copy
number variation which needs to be distinguished from
pathogenic change [2]. Among these new syndromes is
the 8p23.1 duplication between the 8p23.1 olfactory
receptor/defensin repeats (ORDRs) at REPD in distal
8p23.1 (REPeat Distal) and REPP (REPeat Proximal) in
proximal 8p23.1 (Table 1). This genomic disorder is the
reciprocal of the 8p23.1 deletion syndrome [3] and has,
to our knowledge, only been confirmed at the molecular
level in four families to date [4,5]. Duplications of
8p23.1 have been associated with a variable phenotype
that may include one or more of developmental delay,
mild dysmorphism and heart defects. The single prena-
tal case had only mild dysmorphism and normal devel-
opment at the age of 15 months with no evidence of a
heart defect (Case 1 [5]).
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v a r i e t yo fs i m p l ea n dc o m p lex chromosome rearrange-
ments [6] and are themselves copy number variable with
2 to 7 copies of the beta defensin components in the
normal population [7]. Numbers as high as 9 to 12
become cytogenetically visible as “euchromatic variants”
[7] that are only associated with a predisposition to
psoriasis [8]. These high level copy number variations
are cytogenetically indistinguishable from the 8p23.1
duplications [4] and both the copy number variants and
genuine duplications can be transmitted from parents to
children. Here we report on our experience of using fol-
low-up MLPA and FISH testing of apparent cytogenetic
duplications of 8p23.1 detected during prenatal diagno-
sis. The four cases include two de novo duplications, a
paternally transmitted duplication of 8p23.1 and a
benign maternally transmitted defensin copy number
variation.
Methods
Amniotic fluid cells were cultured, G-banded and analysed
using established techniques. Quantitative Fluorescent
Polymerase Chain Reaction (QF-PCR) analysis was per-
formed using an autosomal multiplex according to a
method adapted from Mann et al [9] (Case 1). DNA was
extracted using a Qiagen EZ1 machine and MLPA [10]
was carried out according to the manufacturer’s instruc-
tions with the P139 defensin kit which contains 29 probes
mapping across the distal short arm of chromosome 8
(Cases 1 and 4) (Table 1) (please see the MRC-Holland
Table 1 MLPA and BAC FISH results in Cases 1 to 4
Band BAC/MLPA* Mb from telomere
(hg 18 Build 36)
Case 1
Proband
Case 2
Proband
Case 3
Proband,
sister and
father
Case 4
Proband
and mother
8p23.3 RP11-410N18 1,980,652-2,132,993 - Normal - -
8p23.2 RP11-159F11 2,215,497-2,435,332 - Normal - -
8p23.2 CSMD1 (4 probes)* 2,780,282-4,839,736 Normal - - Normal
8p23.1 CTD-2629I16 6,684,740-6,685,317 - Normal Normal -
8p23.1 ANGPT2* 6,347,22 -6,408,174 Normal - - Normal
8p23.1 DEFB1 (2 probes)* 6,715,511-6,722,939 Normal - - Normal
8p23.1 DEFA6 (2 probes)* 6,769,631-6,771,008 Normal - - Normal
8p23.1 DEFA4 (2 probes)* 6,780,755-6,783,196 Normal - - Normal
8p23.1 DEFA5* 6,900,239-6,901,669 Normal - - Normal
REPD RP11-594D21 7,105,087-7,258,467 - Normal - -
REPD RP11-122N11 7,295,548-7,305,838 - _ dup -
REPD RP11-1118M6 7,286,844-7,462,059 - dup _ -
REPD RP11-774P7 7,318,738-7,396,455 - Normal _ -
REPD DEFB4 etc (10 probes)* 7,789,609-7,791,647
Complex
Normal _ _ trp
8p23.1 RP11-211C9 8,504,285-8,677,721 _ dup dup -
8p23.1 MFHAS1 (MASL1)* 8,679,409-8,788,541 dup _ _ Normal
8p23.1 PPP1R3B* 9,031,186-9,045,630 dup _ _ Normal
8p23.1 TNKS* 9,450,855-9,677,266 dup _ _ Normal
8p23.1 MSRA* 9,949,189-10,323,803 dup _ _ Normal
8p23.1 BLK* 11,388,930-11,459,516 dup _ _ Normal
8p23.1 GATA4* 11,599,162-11,654,918 dup _ _ Normal
8p23.1 RP11-589N15 11,627,380-11,803,128 - dup dup -
REPP RP11-351I21 12,233,365-12,434,472 - dup _ -
REPP RP11-24D9 12,433,487-12,590,982 - - dup -
8p22 RP11-433L7 14,278,096-14,461,154 - - Normal -
8p22 MSR1* 16,009,758-16,094,671 Normal - - Normal
8p21.3 CGAT1* 19,305,952-19,584,374 Normal - - Normal
Letters in bold highlight the G-dark bands, REPD and REPP and the results with a change in copy number.
Dashes indicate probes “not tested” and longer dashes (in bold) those “not tested” but expected to show copy number change based on the other results.
BAC names are given without italics and the genes targeted by MLPA probes in italics.
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were separated on an ABI 3100 Sequencer, analysed using
Applied Biosystems Inc Genotyper version 2.0 (Table 1)
and the results collated in an in-house Excel spreadsheet
as previously described [11]. Array CGH was carried
out with the BlueGnome Cytochip Focus BAC array and
BlueFuse software according to the manufacturer’s
instructions with minor modifications [12] (Case 1).
FISH was carried out using standard methods with
Ensembl 37 k cloneset bacterial artificial chromosomes
(BACs) (Table 1) chosen from the Ensembl web browser
http://www.ensembl.org/Homo_sapiens/Location/Genome
(Cases 2 and 3). The BACs were grown, validated and pre-
pared for FISH by the National Genetics Reference
Laboratory (Wessex). Additional BAC FISH was per-
formed in Case 2 as previously reported [13].
Results
Case and family reports
Case 1 (de novo pathogenic 8p23.1 duplication): A
G2P1 lady of 31 was referred for amniocentesis at 21
+2 weeks gestation after a hypoplastic left heart (HLH)
has been detected with ultrasound in her unborn
daughter. Her previous son (with a different partner)
had been phenotypically normal at term and there was
no family history of congenital heart defects. She was a
non-smoker who had taken no alcohol or drugs during
pregnancy. Following genetic counselling at 25 weeks,
the parents decided to continue the pregnancy and an
infant girl was delivered at 41 weeks gestation with
apgar scores of 7 at 1 min and 9 at 5 min. This girl
weighed 3.3 kg (50th centile), was 53 cm long (just
above 50th centile) and had a head circumference of
38 cm (97th centile). She underwent successful first
stage Norwood surgery for HLH at the age of 2 days.
On examination, at just under 3 months of age, she
was only 4.26 kg in weight (0.4th centile) and 55 cm in
length despite tolerating her feeds well. She was being
treated with Cephalexin for an E. Coli infection but
was otherwise considered well. A transthoracic echo-
cardiogram showed a corrected atrial septum, mild
right atrioventricular valvular regurgitation, no neo-
aortic regurgitation, an RV-PA conduit maximum velo-
city (V max) of 3.7 m/sec, arch turbulence V max of
2.7 m/sec and good ventricular function. Blood pres-
sure was 60/50 in the right legw i t hs a t u r a t i o n so f8 2 %
in air. Cardiovascular examination revealed a single
s e c o n dh e a r ts o u n da n dn o r m a lf i r s th e a r ts o u n d s .
There was a 3/6 ejection systolic murmur in the left
upper sternal area. The chest was clear and her abdo-
men soft. Cardiac catheterization was planned. The
mother reported no breathlessness in her daughter and
had no other concerns.
Case 2 (de novo pathogeneic 8p23.1 duplication): A
lady of 38 was referred for prenatal diagnosis at 18 weeks
gestation because of her advanced maternal age. No
anomalies were seen with ultrasound at the time but a
muscular VSD was detected during an ultrasound scan at
22 weeks. A boy was delivered at 41 weeks and one day
of pregnancy with weight 2920 g (10-25th centile), length
48 cm (10-25th centile) and OFC 35 cm (50th centile).
Apgar scores were 10/10/10. He was healthy and had no
dysmorphic stigmata. Sonographic investigation of the
brain was normal. Cardiac echogram showed a muscular
VSD, a small bidirectional shunt, PDA, an open foramen
ovale, thickened aortic valve and no stenosis. At two
months of age a systolic heart murmur was noted.
Case 3 (pathogenic paternally inherited 8p23.1 dupli-
cation): A G4P2A1 lady was referred for prenatal diag-
nosis, during her fourth pregnancy, due to an advanced
maternal age of 35. No ultrasound anomalies were
recorded. The mother was a healthy Caucasian who had
been through secondary education. Her family history
included a mentally retarded brother, who had died at
the age of 35 (of unknown causes), and a maternal
nephew with learning difficulties who had only attended
primary school. Her karyotype was normal.
The mother’s first pregnancy had ended in a sponta-
neous abortion at 20 weeks gestation. No fetal pathology
records were available. During her second pregnancy,
the mother had been hospitalized at 25 weeks gestation
because of the threat of an early delivery. The pregnancy
resulted in the eutocic pre-term delivery of a female of
2780 g with an apgar score of 9 at 1 minute. This girl
was hospitalized for two days after birth with a systolic
II/IV heart murmur, hyperbilirubinemia, clinical sepsis
and a benign congenital cardiopathy consisting of a
bicuspid aortic valve and very slight valvular pulmonary
stenosis. Global developmental delay was diagnosed
when she was 8 years old and she had special educa-
tional needs. Her 8p23.1 duplication was identified after
the same duplication was found in her mother’sf o u r t h
pregnancy (see below) and, at 15 years of age, she pre-
sented with global developmental delay, psycho-motor
delay, speech impairment (dysarthrophonia) and cogni-
tive and socio-emotional difficulties (selective mutism).
The mother’s 3rd pregnancy ended in a dystocic full
term delivery of a healthy girl of 3200 g. This child had
normal development and a normal karyotype.
T h ef a m i l yw a ss t u d i e da f t er the 8p23.1 duplication
was found in the mother’s fourth pregnancy and 8p23.1
duplications were identified in the father and this cou-
ple’s first liveborn child. The pregnancy was legally ter-
minated at 24 weeks due to the paternally inherited
8p23.1 duplication identified in the fetus and the psy-
chomotor development delay found in their first child
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of the male fetus revealed a left hydroureter and hydro-
nephrosis of the kidney, a meso-septal interventricular
defect of the heart and cerebral oedema of the brain.
Microscopically, nodular hyperplasia of the adrenal cor-
tex, pleural oedema, bilateral dilatation of the alveoli
with disruption of the alveolar walls and an emphy-
sema-like presentation were observed. The weight and
maturity of the placenta were equivalent to a later gesta-
tional age of 29 weeks with evidence of oedema and vil-
litis of unknown etiology.
The father was a Caucasian of 45 years of age with
no relevant family history. He had bilateral conductive
h e a r i n gl o s sa n de x o s t o s e sw hich had been surgically
removed without clinical improvement. He had only
attended primary education and the referring physi-
cian described him as “slow”.H eh a dt h es a m ed u p l i -
cation of 8p23.1 that had been transmitted to his
daughter.
Case 4 (benign maternally inherited defensin copy
number variant): A 27 year old lady was referred at 16
+6 weeks gestation for prenatal diagnosis because of an
increased risk of Down syndrome estimated, by nuchal
translucency determination, at a combined risk of 1 in
235. The pregnancy continued and a phenotypically nor-
mal girl was born at term.
Molecular cytogenetic and molecular genetic
results
Case 1
QF-PCR analysis showed no evidence of trisomy 13, 18
or 21 and FISH investigation of cultured cells with the
Vysis TUPLE1 (HIRA) probe for 22q11.2 showed a nor-
mal hybridisation pattern. However, conventional cyto-
genetic analysis showed a duplication within the short
arm of chromosome 8 at 8p23.1 (Figure 1A). The
abnormality was confirmed in a fetal blood sample. Par-
ental blood karyotypes were normal and the duplication
had arisen de novo. MLPA analysis showed that 6 of the
29 probes located between REPD and REPP, including
GATA4, were duplicated. Retrospective BAC array CGH
analysis revealed increased average intensity ratios for a
3.87- 6.12 Mb region spanning 6 clones from RP11-
347L3 to RP11-247B12 (Figure 2A). In accordance with
ISCN 2009 [14], the karyotype was: 46, XX, dup(8)
(p23.1p23.1)dn.mlpa 8p23.1(P139)x3.arr 8p23.1(RP11-
347L3-RP11-247B12)x3.
Case 2
A duplication of 8p23.1 was suspected during conven-
tional chromosome analysis of the amniotic fluid cultures
(Figure 1B) and confirmed using FISH with a total of
nine BACs. Only BACs mapping to and between REPD
and REPP were duplicated (Figure 2B-2E) (Table 1). BAC
B A
D
C
E F
Figure 1 G-banded partial karyotypes (A-F). (A) Case 1, (B) Case 2, (C) the Case 3 proband, (D) the father of the proband, (E) the elder sister
of the proband and (F) Case 4. The duplicated or variant chromosome is on the right hand side of each chromosome pair and the expanded
G-light region of 8p23.1 indicated by the black arrow in each case. Note the similarity of the G-banded copy number variant 8 in Case 4 to the
duplicated 8 s in the probands of Cases 1 to 3.
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with BlueFuse software and showing the region of copy number gain at 8p23.1 (green bar to the right of the idiogram); Case 2 (B-E): (B) the
larger metaphase signals (arrowed) from the 8p23.1 BACs RP11-211C9 (red) and RP11-589N15 (green) and (C) the enhanced signal strength from
BAC RP11-211C9 (red) at metaphase (single red arrow) and the duplicated signals at interphase (double red arrows) (note, the green signals are
from BAC CTD-2629I168 and the 8 centromere which both had normal copy number); (D) the normal results from BAC RP11-594D21 (red) in
distal REPD and a control BAC RP11-410N18 from 8p23.3 (green); (E, left hand pairs) the duplicated signals (vertical arrows) from BACs RP11-
351I21 (red) in REPP and RP11-1118M6 (green) in REPD from the fetus and (E, right hand pairs) the normal copy in the mother. Case 3 (F-H): (F)
the enhanced metaphase signal strength (red and green arrows) from the REPD BACs RP11-122N11 (red) and RP11-589N15 (green) note, (the
additional red signals are from the 8 centromere); (G) the duplicated metaphase signals (single green arrow) from BAC RP11-211C9 (green) and
(H) at prometaphase (red and green arrows) from BAC RP11-24D9 (red) in REPP from BAC RP11-589N15 (green).
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(Figure 2D) while REPD BAC RP11-1118M6 was dupli-
cated (Figure 2E) and RP11-774P7 gave a normal result
despite being proximal to RP11-1118M6 (data not
shown). This may reflect additional structural complexity
or uncertainties in the assembly of the human genome in
this sequence gap. Normal karyotypes were found in
both parents and the duplication was de novo. The kar-
yotype of the fetus was: 46, XY, dup(8)(p23.1p23.1)dn.ish
dup(8)(RP11-410N18+,RP11-159F11+,CTD-2629I16+,
RP11-594D21+, RP11-1118M6++, RP11-774P7+,RP11-
211C9++,RP11-589N15++, RP11-351I21++).
Case 3
A duplication of 8p23.1 was suspected during conven-
tional chromosome analysis of the amniotic fluid cul-
tures (Figure 1C) and confirmed using FISH with six
BACs. Both the BACs which map to either end of the
interval between REPP and REPD were duplicated (Fig-
ure 2F-2H) as were the BACs which map to the REPP
and REPD repeats (Figure 2F and 2H) (Table 1). Con-
ventional chromosome analysis on the father (Figure
1D) and the family’s eldest daughter (Figure 1E) showed
the same duplication which was confirmed using FISH
on peripheral blood from the father and daughter using
the same set of BACs (Table 1). The mother had a nor-
mal karyotype and the normal karyotype of her middle
daughter was confirmed using FISH. The karyotype of
this boy was: 46, XY, dup(8)(p23.1p23.1)pat.ish dup(8)
(CTD-2629I16+,RP11-122N11++,RP11-211C9++,RP11-
589N15++,RP11-24D9++,RP11-433L7+).
Case 4
A duplication of 8p23.1 was suspected during conven-
tional chromosome analysis of the amniotic fluid cul-
tures (Figure 1F) and a similar chromosomal pattern
was seen in the mother. The normal results at the six
genes between REPD and REPP specifically excluded a
duplication of 8p23.1 using MLPA with DNA from the
fetus and mother. However, there was clear evidence for
at least four copies (triplication) of the 8 genes within
the copy number variable defensin cluster in both the
fetus and mother (data not shown). These include
DEFB4, SPAG11, DEFB103A, DEFB104, DEFB105,
DEFB106, DEFB107 and DEFB108. This copy number
variation had been transmitted from the phenotypically
normal mother and the pregnancy continued. In accor-
dance with ISCN 2009 [14], the karyotype of the fetus
was: 46, XX, var(8)(p23.1p23.1).mlpa 8p23.1(P139)x4
mat.
Discussion
We have presented four prenatal cases in which an
8p23.1 duplication was suspected on cytogenetic
grounds. MLPA or FISH confirmed 8p23.1 duplication
syndrome in Cases 1 to 3 and only copy number
variation of the defensin cluster in Case 4. Cases 1 and
2w e r ede novo, the duplication in Case 3 was directly
transmitted from the father and the copy number varia-
tion in Case 4 was maternally transmitted. It is reason-
able to conclude that Cases 1 to 3 all had a core
duplication of ~3.75 Mb between the proximal and dis-
tal ORDRs (REPD and REPP) as shown using array
CGH in Case 1 (Figure 2A, Figure 3). When these cases
are added to those in the literature, the 8p23.1 duplica-
tion has now been confirmed, using molecular cytoge-
netic methods, in eleven individuals of whom four cases
were de novo and another four had duplications trans-
mitted from a father and two mothers (Table 2). An
estimate of the prevalence of this condition can be
derived from a recent series of 2,419 diagnostic patients
analysed using oligonucleotide array CGH [15]; one dup
(8)(p23.1p23.1) was found compared with sixteen
22q11.2 DiGeorge/Velocardiofacial syndrome (DG/
VCFS) deletions. As DG/VCFS has a population fre-
quency of ~1 in 4,000 [16], the 8p23.1 duplication syn-
drome has an estimated prevalence of 1 in 64,000. No
examples of the full 8p23.1 duplication syndrome region
have been reported among the 29,133 CNVs currently
in the Database of Genome Variants (DGV) http://pro-
jects.tcag.ca/variation/ (Figure 3).
A summary of the phenotypic data on the eleven
patients with 8p23.1 duplication syndrome is provided
in Table 2. Ascertainment has been as a result of conge-
nital heart disease (CHD) in only one of four prenatal
cases and one of three postnatal probands but is now
the most common single feature having been found in
6/11 individuals. Developmental delay and/or learning
difficulties have been found in 5/11 but, of the remain-
ing 6/11, one prenatal case was developmentally normal
at 15 months of age and the three prenatal cases
reported here have not yet reached an age at which this
can assessed. A variable degree of facial dysmorphism
was also present in 5/11 individuals. These results are
broadly in line with those of Tsai et al [17] but, unfortu-
nately, their results rely on cytogenetics alone and do
not differentiate between the duplications and copy
number variants. By contrast, partial toe syndactyly has
been found in only one mother and son and adrenal
anomalies in two probands but not in the mother, of
one of these two, who had the same duplication.
Excluding the copy number variable regions, REPP
and REPD, the duplicated interval contains 57 genes of
which 34 are known and 23 are novel. These include
the two transcription factors GATA4 and SOX7 and
three micro-RNA loci. Deletions and heterozygous loss
of function mutations of the GATA binding protein 4
gene (GATA4, OMIM *600576) are already strongly
associated with conotruncal and septal heart defects
[3,18-23] and it has been proposed that duplication of
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Tetralogy of Fallot found in two of the four published
probands with 8p23.1 duplication syndrome [4,5]. The
idea that GATA4 is responsible for the heart defect
component of the 8p23.1 duplication syndrome is
strengthened by the hypoplastic left heart in Case 1, the
complex VSD in Case 2, the meso-septal interventricular
heart defect in Case 3, at autopsy, and the mild heart
defect in the eldest sister of Case 3.
The existence of a second heart disease gene in a 5-cM
region of 8p23.1 between WI-8327 and D8S1825
(6,469,539 to 8,962,119 base pairs according to UCSC,
March 2006) was proposed by Giglio et al [24] (Figure 3).
However, the overlap between this ~2.5 Mb region and
the REPD to REPP interval contains only four single copy
genes (Figure 3), of which neither PRAGMIN, CLDN23
(*OMIM 609203), MFHAS1 (OMIM *605352) nor ERI1
(OMIM *608739) are currently good candidates for heart
disease. Thus, it seems more likely that the absence of
heart disease in some 8p23.1 duplication syndrome pro-
bands [5], four members of a family with a 133 kb micro-
duplication of the GATA4 gene [25] and seven
individuals with a 4.37 Mb duplication of 8p23.1 to 8p22
that included GATA4 [26], is more likely to reflect non-
penetrance rather than the existence of a further heart
disease gene between REPP and REPD. Normal heart
development is thought to require interaction between
GATA4 and the T-Box 5 (TBX5) gene [19,27] which sug-
gests that variation in TBX5, or other genes involved in
the development of the heart, might modify the conse-
quences of altered GATA4 d o s a g e .W ec o n c l u d et h a t
both duplication and deletion of the GATA4 gene can
give rise to a variety of conotruncal and septal heart
defects but with variable penetrance and expressivity.
Other candidate genes derived from atypical microde-
letions of proximal 8p23.1 may be considered candidate
genes for features of the 8p23.1 duplication syndrome
[3,28] (Figure 3). These include the TRF1-interacting,
ankyrin related ADP-ribose polymerase gene (TNKS,
OMIM*603303) for behavioural difficulties, and the
SRY-Box 7 transcription factor (SOX7, OMIM *612202)
for the developmental delay, as mutations of the related
SOX3 gene have been associated with X-linked mental
retardation [28]. By contrast, the diaphragmatic hernia
found in a number of patients with the reciprocal dele-
tion syndrome [29-31] has not, to our knowledge, been
recorded in any 8p23.1 duplication syndrome patient to
date.
There was evidence, using FISH, for both REPD and
REPP being included in the duplication in Case 2 (Fig-
ure 2E) and Case 3 (Figure 2F and 2H) but not for the
inclusion of either repeat in Case 1 using MLPA. REPP
Figure 3 Annotated screenshot of 5.7 Mb of band 8p23.1 (UCSC Genome Browser on Human Mar. 2006 Assembly (hg18)).F r o m
bottom to top: the Segmental Duplications that contain the Olfactory Receptor and Defensin Repeats (ORDRs) are labelled REPD and REPP; the
~3.75 Mb core 8p23.1 duplication syndrome interval between REPD and REPP [5] and the ~2.5 Mb alternative CHD region proposed by Giglio et
al [24] are illustrated by annotated boxes; the multiple copy number variations of REPD and REPP in the Database of Genome Variants (DGV)
http://projects.tcag.ca/variation/ is indicated by the red, blue and green lines and the common polymorphic inversion between REPD and REPP
by the purple lines; OMIM Morbid genes appear as red boxes and other OMIM genes as blue boxes (or lines); acronyms for the OMIM genes
specifically mentioned in the text have been added above in corresponding colours. Note that the DGV does not contain any CNVs that match
the 8p23.1 duplication syndrome region.
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(Family 1 [5]). Altered copy number might be expected
at either or both repeats if the reciprocal deletions and
duplications are generated by ectopic recombination (or
NAHR) between the repeats [6]. Alternatively, altered
copy number may be due to independent copy number
variation of the ORDRs themselves.
Benign copy number variation of the defensin cluster
was found in over 14% of a recent series of 1,275
patients analysed using array CGH [32], but cytogeneti-
cally visible amplifications, of the kind found in Case 4,
are uncommon. These segregate in families with no sig-
nificant clinical or reproductive effects other than a pre-
disposition to Crohn’s disease at low copy number [33]
and psoriasis at high copy number [8]. Most chromo-
somes 8 have two copies of the defensin cluster and
most individuals a total of four [34]. Thus, the triplica-
tion of the defensin cluster, relative to control DNA,
Table 2 Features of the present and previous cases of the 8p23.1 duplication syndrome
Physical
findings
at birth or
diagnosis
Present
Case 1
Present
Case 2
Present
Case 3
Proband
Present
Case 3
Sister
Present
Case 3
Father
Barber
et al.
(2008)
Case 1
Barber
et al.
(2005)
Case 1
Barber
et al.
(2008)
Family 1
Proband
Barber
et al.
(2008)
Family 1
Mother
Barber
et al.
(2008)
Family 2
Proband
Barber
et al.
(2008)
Family
2
Mother
Ascertainment
of dup(8)
CHD AMA AMA AMA AMA 1:150
risk
DD;
CHD
PNAI Daughter DYS Son
Prenatal/
Postnatal
Pre Pre Pre Pre Pre Pre Post Post Post Post Post
Pregnancy
continued
Y Y N n/a n/a Y n/a n/a n/a n/a n/a
Sex F M M F M F F F F M F
Delivery
gestation (wks)
41 41+1 22 < 40 n/a 40 n/k 42 n/a 40+5 n/a
Apgar
scores
7;9 10;10;10 n/a 9 n/a 8;9 n/a n/a n/a n/a n/a
Birth
weight (kg)
3.3 2.92 n/r 2.78 n/k 3.15 n/k 3.6 ? 3.39 ?
OFC (cm) 38 35 n/r ? n/k 33.6 n/k n/r n/k 39.5 ?
Age at
examination
3/12 Neonate 22/52 15 45 15/12 8 4 n/r 22/12 n/r
Developmental
delay
n/a n/a n/a ++ ? n + - - - +
Learning
difficulties
n/a n/a n/a + + n/a + - + - +
Facial
dysmorphism
- - - - - + + +/- + ++ ++
Congenital
heart defects
++ ++ + ++ - n + + - - -
Neurological
defects
-n ? + + - n - + - - -
Syndactyly - - - - - - - - - + +
Adrenal
anomalies
--+- - - - + + - - -
Hydronephrosis
and
hydroureter
- - + - - - - --- -
Alveolar
anomalies
- - + - - - - --- -
Hearing
loss
- - - - + - - --- -
Exostoses - - - - + - - - - - -
AMA: Advanced Maternal Age; CHD: Congenital heart defect; DD: Developmental delay;
DYS: Facial dysmorphism; n: no evidence; n/a: not applicable; n/k: not known; n/r: not recorded; PNAI: Primary Neonatal Adrenal Insufficiency; Y = Yes;
+ = present; - = absent.
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mother. If the normal chromosome 8 had 2 copies, the
variant chromosome would have 10 copies of the ORDR
repeat and, as the repeat is a minimum of 240 kb in size
[7], the ORDR array would extend to at least 2.4 Mb
and thus become cytogenetically visible in the light
microscope (Figure 1F) [4,7].
Both FISH and MLPA have been reliably used to con-
firm or exclude an 8p23.1 duplication between REPD
and REPP. However, even normal chromosomes 8 can
look duplicated with BACs that map to these repeats
and thus differential signal strength between FISH
probes does not constitute proof that copy number var-
iation of REPD or REPP is the cause of an increase in
the size of the 8p23.1 band. Recent evidence also sug-
gests that the defensin clusters are switched between
REPD to REPP by the polymorphic inversion between
t h e m[ 3 5 ] ,a n dt h i sm a yb ee x p e c t e dt oc h a n g et h e
appearance of the FISH signals seen on homologous
pairs of chromosome 8 even if their copy number is the
same or similar. Array CGH will also discriminate the
duplication from the variant, and exclude additional
imbalances, but careful choice of control samples may
be required to accurately confirm the extent of the
defensin copy number variation in all cases.
Conclusions
In conclusion, our results underline the need to distin-
g u i s ht h e8 p 2 3 . 1d u p l i c a t i o nf r o mb e n i g nd e f e n s i nc o p y
number variation at prenatal diagnosis. Direct transmis-
sion of duplications and copy number variants from a
parent to a child has been found on multiple occasions
and transmission does not therefore discriminate
between copy number variations of the defensin cluster
and the 8p23.1 duplication syndrome. Cardiac defects
were ascertained by ultrasound in only one of the three
duplication 8p23.1 pregnancies but were visible in two
of the three at 21 to 22 weeks gestation. Phenotypic
data also indicate a relatively mild but variable syn-
drome and support the idea that duplication of the
GATA4 transcription factor can give rise to a variety of
conotruncal or septal heart defects with variable pene-
trance and expressivity.
List of abbreviations
AMA: Advanced maternal age; BAC: Bacterial Artificial
Chromosome; array CGH: array Comparative Genomic
Hybridisation; CHD: Congenital heart disease; DGV:
Database of Genome Variants; DNA: De-oxyo Ribose
Nucleic Acid; FISH: Fluorescence In Situ Hybridisation
HLH: Hypoplastic Left Heart; MCA: Multiple Congeni-
tal Anomalies; Multiple Ligation-dependent Probe
Amplification (MLPA); OFC: Occipito-Frontal Circum-
ference; PDA: Patent Ductus Arteriosus; ORDR:
Olfactory Receptor and Defensin Repeat; Patent Ductus
Arteriosus; PNAI: Primary Neonatal Adrenal Insuffi-
ciency; QF-PCR: Quantitative Fluorescent Polymerase
Chain Reaction; REPD: REPeat Distal; REPP: REPeat
Proximal; VSD: Ventricular Septal Defect.
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